Literature DB >> 18515794

Early childhood infection by human herpesvirus 8 in Zambia and the role of human immunodeficiency virus type 1 coinfection in a highly endemic area.

Veenu Minhas1, Kay L Crabtree, Ann Chao, Tendai J M'soka, Chipepo Kankasa, Marc Bulterys, Charles D Mitchell, Charles Wood.   

Abstract

Kaposi's sarcoma occurs at high incidence among Zambian adults and children, but there is a paucity of data on human herpesvirus 8 (HHV-8) incidence and routes of infection, especially in children. Between 1998 and 2004, the authors conducted a prospective study of viral transmission in a cohort of 684 children in Lusaka, Zambia, to estimate the annual incidence of HHV-8 from birth through 48 months of age. Maternal and pediatric human immunodeficiency virus type 1 (HIV-1) infection status was also determined. The results, based on 1,532 child-years of follow-up, showed that HHV-8 seroconversion occurs early in life. The incidence rate of HHV-8 seroconversion was 13.8 infections per 100 child-years by 48 months of age. HIV-1-infected children were at substantially higher risk for HHV-8 seroconversion (adjusted hazard ratio = 4.60, 95% confidence interval: 2.93, 7.22). Maternal HIV-1 and HHV-8 infection status were not independently associated with risk of HHV-8 seroconversion in the child. HHV-8 antibody titers in children followed at all consecutive time points revealed sero-reversion of HHV-8 antibodies, with undetectable titers in some children at one or more time points after seroconversion. These results demonstrate that cross-sectional serologic screening probably underestimates true HHV-8 seroprevalence in young Zambian children because of fluctuations in detectable antibody titers.

Entities:  

Mesh:

Year:  2008        PMID: 18515794      PMCID: PMC2727264          DOI: 10.1093/aje/kwn125

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  51 in total

1.  Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection.

Authors:  M J Cannon; S C Dollard; D K Smith; R S Klein; P Schuman; J D Rich; D Vlahov; P E Pellett
Journal:  N Engl J Med       Date:  2001-03-01       Impact factor: 91.245

Review 2.  Sorting out the new HSV type specific antibody tests.

Authors:  R L Ashley
Journal:  Sex Transm Infect       Date:  2001-08       Impact factor: 3.519

3.  Vertical transmission of Kaposi's sarcoma-associated herpesvirus.

Authors:  H Mantina; C Kankasa; W Klaskala; B Brayfield; J Campbell; Q Du; G Bhat; F Kasolo; C Mitchell; C Wood
Journal:  Int J Cancer       Date:  2001-12-01       Impact factor: 7.396

4.  Human herpes virus-8 infection among pregnant women and their children: results from the Sardinia-IDDM Study 2.

Authors:  D Serraino; M Locatelli; M Songini; R Cirillo; G F Bottazzo; M Andreoni; S Franceschi; G Rezza
Journal:  Int J Cancer       Date:  2001-03-01       Impact factor: 7.396

5.  Longitudinal sero-reactivity to human herpesvirus 8 (KSHV) in the Swiss HIV Cohort 4.7 years before KS.

Authors:  E B Quinlivan; R X Wang; P W Stewart; C Kolmoltri; N Regamey; P Erb; P L Vernazza
Journal:  J Med Virol       Date:  2001-06       Impact factor: 2.327

6.  Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population.

Authors:  S Plancoulaine; L Abel; M van Beveren; D A Trégouët; M Joubert; P Tortevoye; G de Thé; A Gessain
Journal:  Lancet       Date:  2000-09-23       Impact factor: 79.321

7.  Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia.

Authors:  Carolyn Bolton-Moore; Mwangelwa Mubiana-Mbewe; Ronald A Cantrell; Namwinga Chintu; Elizabeth M Stringer; Benjamin H Chi; Moses Sinkala; Chipepo Kankasa; Craig M Wilson; Catherine M Wilfert; Albert Mwango; Jens Levy; Elaine J Abrams; Marc Bulterys; Jeffrey S A Stringer
Journal:  JAMA       Date:  2007-10-24       Impact factor: 56.272

8.  Mother-to-child transmission of human herpesvirus-8 in South Africa.

Authors:  Martin Dedicoat; Robert Newton; Khaled R Alkharsah; Julie Sheldon; Ildiko Szabados; Bukekile Ndlovu; Taryn Page; Delphine Casabonne; Charles F Gilks; Sharon A Cassol; Denise Whitby; Thomas F Schulz
Journal:  J Infect Dis       Date:  2004-08-11       Impact factor: 5.226

9.  Antibody reactivity to latent and lytic antigens to human herpesvirus-8 in longitudinally followed homosexual men.

Authors:  Robert J Biggar; Eric A Engels; Denise Whitby; Dean H Kedes; James J Goedert
Journal:  J Infect Dis       Date:  2002-12-13       Impact factor: 5.226

Review 10.  Review of the distribution of Kaposi's sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi's sarcoma.

Authors:  M Dedicoat; R Newton
Journal:  Br J Cancer       Date:  2003-01-13       Impact factor: 7.640

View more
  35 in total

1.  High prevalence of early childhood infection by Kaposi's sarcoma-associated herpesvirus in a minority population in China.

Authors:  Y Cao; V Minhas; X Tan; J Huang; B Wang; M Zhu; Y Gao; T Zhao; L Yang; C Wood
Journal:  Clin Microbiol Infect       Date:  2013-08-28       Impact factor: 8.067

2.  Risk Factors for Kaposi's Sarcoma-Associated Herpesvirus DNA in Blood and in Saliva in Rural Uganda.

Authors:  Angela Nalwoga; Marjorie Nakibuule; Vickie Marshall; Wendell Miley; Nazzarena Labo; Stephen Cose; Denise Whitby; Robert Newton
Journal:  Clin Infect Dis       Date:  2020-08-14       Impact factor: 9.079

Review 3.  Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma.

Authors:  Thomas S Uldrick; Denise Whitby
Journal:  Cancer Lett       Date:  2011-03-04       Impact factor: 8.679

Review 4.  Serodiagnosis for tumor viruses.

Authors:  Brian J Morrison; Nazzarena Labo; Wendell J Miley; Denise Whitby
Journal:  Semin Oncol       Date:  2014-12-31       Impact factor: 4.929

5.  Early childhood infection of Kaposi's sarcoma-associated herpesvirus in Zambian households: a molecular analysis.

Authors:  Landon N Olp; Danielle M Shea; Maxine K White; Clement Gondwe; Chipepo Kankasa; Charles Wood
Journal:  Int J Cancer       Date:  2012-08-20       Impact factor: 7.396

6.  High seroprevalence of antibodies against Kaposi's sarcoma-associated herpesvirus (KSHV) among HIV-1-infected children and adolescents in a non-endemic population.

Authors:  Cornelia Feiterna-Sperling; Christoph Königs; Gundula Notheis; Bernd Buchholz; Renate Krüger; Katharina Weizsäcker; Josef Eberle; Nikola Hanhoff; Barbara Gärtner; Harald Heider; Detlev H Krüger; Jörg Hofmann
Journal:  Med Microbiol Immunol       Date:  2016-05-30       Impact factor: 3.402

7.  Update on HHV-8-Associated Malignancies.

Authors:  Meena Sunil; Erin Reid; Mary Jo Lechowicz
Journal:  Curr Infect Dis Rep       Date:  2010-03-26       Impact factor: 3.725

8.  Primary gamma-herpesviral infection in Zambian children.

Authors:  Veenu Minhas; Brad P Brayfield; Kay L Crabtree; Chipepo Kankasa; Charles D Mitchell; Charles Wood
Journal:  BMC Infect Dis       Date:  2010-05-12       Impact factor: 3.090

9.  Kaposi's Sarcoma Associated-Herpes Virus (KSHV) Seroprevalence in Pregnant Women in South Africa.

Authors:  Babatyi I Malope-Kgokong; Patrick Macphail; Georgina Mbisa; Edith Ratshikhopha; Mhairi Maskew; Lara Stein; Freddy Sitas; Denise Whitby
Journal:  Infect Agent Cancer       Date:  2010-08-31       Impact factor: 2.965

10.  Risk factors for early childhood infection of human herpesvirus-8 in Zambian children: the role of early childhood feeding practices.

Authors:  Kay L Crabtree; Janet M Wojcicki; Veenu Minhas; David R Smith; Chipepo Kankasa; Charles D Mitchell; Charles Wood
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-12-02       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.